FUNCTIONAL STUDIES OF HUMAN EPIDERMAL LANGERHANS CELLS
人表皮朗格汉斯细胞的功能研究
基本信息
- 批准号:3153039
- 负责人:
- 金额:$ 7.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-09-30 至 1986-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This proposed research project involves the intensive study of the
functional properties of human Langerhans cells, with special reference to
functional properties related to their expression of allospecific HLA-DR
antigens. Human epidermal Langerhans cells have been known to express DR
alloantigens and to possess Fc and C3b receptors character istic of cells
of the monocyte/macrophage lineage. However, while some experimental
evidence supports assignment of specific immunological functions such as
stimulation of allogeneic lymphocyts and accessory cell functions, to
guinea pig Langerhans cells, such functional activities have not yet been
studied in relation to human Langerhans cells. Our laboratory has now
developed a procedure for significant enrichment of Langerhans cells. This
procedure, will be further improved and, together with our laboratory's
extensive resources and experience in studies of human histocompatibility
complex, will be used to accomplish the specific objectives of this
proposal. In particular, the proposed research project will involve
functional assays of the DR antigens on Langerhans cells as stimulators of
primary and secondary allogeneic lymphocyte proliferation and as
stimulators and targets of allospecific cytotoxic effector cells. The
project will also involve studies of subpopulations of Langerhans cells
with different surface markers, studies of other Langerhans cell surface
antigens, identified by monoclonal antisera, and functional studies of the
possible role of Langerhans cells as accessory cells for T-cell responses
to mitogens and antigens. The properties studies will be attributed to
Langerhans cells on the basis of comparative effects of enriched and
depleted cells fractions and on the basis of effects of Langerhans cell
elimination and surface marker blocking. In all these studies, the role of
HLA-A,B,C and/or D/DR compatibility will be evaluated in relation to
Langerhans cell interactions with other cell types and to the possible role
of non-HLA antigens expressed on the Langerhans cells or other epidermal
cell types. A better understanding of Langerhans cell functions will
contribute to the general understanding of immunological diseases of the
skin and of the role these cells may play in the initiation of graft versus
host disease in patients receiving therapeutic allogeneic bone marrow
transplantation.
本拟议的研究项目涉及对
人类朗格汉斯细胞的功能特性,特别是
与其同种异体特异性 HLA-DR 表达相关的功能特性
抗原。 已知人类表皮朗格汉斯细胞表达 DR
同种异体抗原并具有细胞的Fc和C3b受体特征
单核细胞/巨噬细胞谱系。 然而,虽然一些实验
有证据支持特定免疫功能的分配,例如
刺激同种异体淋巴细胞和辅助细胞功能,
豚鼠朗格汉斯细胞,这种功能活动尚未被证实
研究了与人类朗格汉斯细胞的关系。 我们实验室现在有
开发了一种显着富集朗格汉斯细胞的程序。 这
程序将进一步改进,并与我们实验室的
在人类组织相容性研究方面拥有丰富的资源和经验
复杂,将用于实现此特定目标
提议。 特别是,拟议的研究项目将涉及
朗格汉斯细胞上 DR 抗原作为刺激物的功能测定
原发性和继发性同种异体淋巴细胞增殖和
同种异体特异性细胞毒性效应细胞的刺激物和靶标。 这
该项目还将涉及朗格汉斯细胞亚群的研究
使用不同的表面标记,对其他朗格汉斯细胞表面的研究
通过单克隆抗血清鉴定的抗原及其功能研究
朗格汉斯细胞作为 T 细胞反应辅助细胞的可能作用
促有丝分裂原和抗原。 属性研究将归因于
朗格汉斯细胞基于富集和富集的比较效果
耗尽的细胞分数并基于朗格汉斯细胞的影响
消除和表面标记阻断。 在所有这些研究中,
HLA-A、B、C 和/或 D/DR 兼容性将根据以下方面进行评估
朗格汉斯细胞与其他细胞类型的相互作用以及可能的作用
朗格汉斯细胞或其他表皮上表达的非 HLA 抗原
细胞类型。 更好地了解朗格汉斯细胞功能将
有助于对免疫性疾病的普遍了解
皮肤以及这些细胞在移植物抗反应启动中可能发挥的作用
接受治疗性同种异体骨髓的患者的宿主疾病
移植。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The use of phytohemagglutinin-stimulated mononuclear cell subpopulations for HLA typing studies involving chronic myelogenous leukemia patients.
使用植物血凝素刺激的单核细胞亚群进行涉及慢性粒细胞白血病患者的 HLA 分型研究。
- DOI:10.1097/00007890-198609000-00020
- 发表时间:1986
- 期刊:
- 影响因子:6.2
- 作者:Callaway,C;Maurer,DH;Brown,D;Fang,W;Fehir,KM;Pollack,MS
- 通讯作者:Pollack,MS
The use of gamma interferon to increase HLA antigen expression on cultured amniotic cells used for the prenatal diagnosis of 21-hydroxylase deficiency.
使用 γ 干扰素增加培养羊膜细胞上的 HLA 抗原表达,用于 21-羟化酶缺乏症的产前诊断。
- DOI:10.1111/j.1749-6632.1985.tb14599.x
- 发表时间:1985
- 期刊:
- 影响因子:5.2
- 作者:Maurer,DH;Pollack,MS
- 通讯作者:Pollack,MS
The immunological detection of a 21-OH deficiency mutation HLA supratype.
21-OH缺陷突变HLA超型的免疫学检测。
- DOI:
- 发表时间:1986
- 期刊:
- 影响因子:9.8
- 作者:Pollack,MS;Keenan,B;Christiansen,FT;Cobain,TJ;Dawkins,RL;Clayton,G
- 通讯作者:Clayton,G
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARILYN S POLLACK其他文献
MARILYN S POLLACK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARILYN S POLLACK', 18)}}的其他基金
IMMUNOGENETIC FACTORS IN THE PROGNOSIS OF HIV INFECTIONS
HIV 感染预后中的免疫遗传因素
- 批准号:
3142409 - 财政年份:1989
- 资助金额:
$ 7.93万 - 项目类别:
IMMUNOGENETIC FACTORS IN THE PROGNOSIS OF HIV INFECTIONS
HIV 感染预后中的免疫遗传因素
- 批准号:
3142408 - 财政年份:1989
- 资助金额:
$ 7.93万 - 项目类别:
IMMUNOGENETIC FACTORS IN THE PROGNOSIS OF HIV INFECTIONS
HIV 感染预后中的免疫遗传因素
- 批准号:
3142407 - 财政年份:1989
- 资助金额:
$ 7.93万 - 项目类别:
FUNCTION/REGULATION OF HLA ANTIGENS ON CULTURED CELLS
HLA 抗原对培养细胞的功能/调节
- 批准号:
3180668 - 财政年份:1986
- 资助金额:
$ 7.93万 - 项目类别:
FUNCTION/REGULATION OF HLA ANTIGENS ON CULTURED CELLS
HLA 抗原对培养细胞的功能/调节
- 批准号:
3180671 - 财政年份:1986
- 资助金额:
$ 7.93万 - 项目类别:
FUNCTION/REGULATION OF HLA ANTIGENS ON CULTURED CELLS
HLA 抗原对培养细胞的功能/调节
- 批准号:
3180670 - 财政年份:1986
- 资助金额:
$ 7.93万 - 项目类别:
GENETIC CONTROL OF FERRITIN SECRETION BY HUMAN MONONUCLE
人单核对铁蛋白分泌的遗传控制
- 批准号:
3153040 - 财政年份:1983
- 资助金额:
$ 7.93万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 7.93万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 7.93万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 7.93万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 7.93万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 7.93万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 7.93万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 7.93万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 7.93万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 7.93万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 7.93万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




